Genetic deletion or pharmacological inhibition of PARP1 was anti-inflammatory against Th2-mediated inflammation in contact hypersensitivity and irritant dermatitis reactions [15–17], while it was pro-inflammatory in the primarily Th17-mediated imiquimod (IMQ)–induced psoriasis model in mice [18]. This evidence concerns the gene PARP1 and psoriasis.